DarioHealth Corp. (DRIO) Fair Value 2026

DRIO · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.0 /10

32 fundamental signals · 3 models active

Value Trap Risk

WARN (53/100)

Quick Summary — As of 2026-08-28, DarioHealth Corp. (DRIO) trades at $6.77, versus a $7.72 median fair value across its 3 active models — 14.1% above the current price. QOC: 6.0/10. Value Trap Risk: 53/100 (WARN). 3/13 models active.

Key Facts

Ticker
DRIO
Price
$6.77
Quality Score
6.0/10
Value Trap Risk
53/100
Models Active
3/13
Last Updated
Strength: FTNN Topology suggests +210.8% upside with 8% confidence
Risk: Value Trap score of 53 suggests caution despite apparent undervaluation

Is DarioHealth Corp. (DRIO) Undervalued or Overvalued in 2026?

According to CirclFi’s 3-model valuation engine, DarioHealth Corp. (DRIO) appears undervalued as of : the median of 3 independent fair value estimates is $7.72, 14.1% above the current price of $6.77. Estimates range from $2.67 to $21.04. DRIO scores 6.0/10 on fundamental quality and 53/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. DRIO’s +14.1% gap is narrower than that market norm, and the Health Information Services sector median is +4.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy DarioHealth Corp. Stock in 2026? →

What Fair Value Does Each Model Give DRIO?

3 Intrinsic Value Models vs. Current Price ($6.77)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $2.67 -60.5%
Option-Based · Medium Conviction
 $7.72 +14.1%
Relative · Low Conviction
 $21.04 +210.8%

All Models Active

All 3 models are displayed above.

What Is DRIO's Fair Value Range?

Spread across 3 independent models · $2.67 to $21.04

CirclFi's 3 active models place DarioHealth Corp. (DRIO) between $2.67 and $21.04 per share, a spread of 238% of the median. The median of that range — $7.72 — is the fair value CirclFi publishes for DRIO, against a current price of $6.77.

Low · ML-RIVHigh · FTNN
$2.67median $7.72$21.04
Where the range comes from
Most bearish modelML Residual Income$2.67
Most bullish modelFTNN Topology$21.04
Model agreement2 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for DRIO. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on DRIO, not a CirclFi price target. How each model works →

What Is DarioHealth Corp. (DRIO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, DarioHealth Corp.'s intrinsic value is estimated at $7.72, suggesting a +14.1% median upside from the current price of $6.77. While 2 models see room for appreciation, model agreement is not unanimous as 1 model flags potential overvaluation. Model dispersion is worth noting: FTNN targets $21.04 (+210.8%), versus ML-RIV at $2.67 (-60.5%). This +271.3% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About DRIO?

3 of 13 models are currently active for DRIO. Of these, 2 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for DRIO is $7.72 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does DRIO Rank in Health Information Services?

Among 55 Health Information Services stocks, DRIO ranks #33 by Quality of Company score. CirclFi's QOC score of 6.0/10 evaluates 32 fundamental signals. A score of 6.0 reflects mixed fundamentals.

See all Most Undervalued Health Information Services Stocks →

DarioHealth Corp. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is DRIO a Value Trap?

CirclFi's Value Trap algorithm assigns DRIO a score of 53/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

3 of 13 models are active for DarioHealth Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, DarioHealth Corp. earns a quality score of 6.0/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

The gap between the most bullish and bearish model spans +271.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every DRIO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across DRIO's 3 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy DarioHealth Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

HTFLHeartflow, Inc.QOC 6.1PBSVPharma-Bio Serv, Inc.QOC 5.9CRVWCareView Communications, Inc.QOC 6.2SOPHSOPHiA GENETICS SAQOC 5.9BFRGBullfrog AI Holdings, Inc.QOC 6.2OMDAOmada Health, Inc.QOC 5.8ONMDOneMedNet CorporationQOC 4.8SPOKSpok Holdings, Inc.QOC 8.6BTSGBrightSpring Health Services, Inc.QOC 7.2DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: HTFL · PBSV · CRVW · SOPH · BFRG · OMDA · ONMD · SPOK · BTSG · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to DRIO?

7 companies across all industries closest to DRIO’s Quality of Company score of 6.0/10.

FLYXflyExclusive, Inc.QOC 6.0ELWTElauwit Connection, Inc.QOC 6.0BCSFBain Capital Specialty Finance, Inc.QOC 6.0ASSTStrive, Inc.QOC 6.0NIQNIQ Global Intelligence plcQOC 6.0BGINBgin Blockchain LimitedQOC 6.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: FLYX · ELWT · BCSF · ASST · NIQ · BGIN · NVDA

Where Does DRIO Sit in CirclFi's Health Information Services Rankings?

DRIO is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About DarioHealth Corp.’s Valuation?

What is DarioHealth Corp.'s intrinsic value in 2026?

CirclFi puts DarioHealth Corp. (DRIO)'s intrinsic value at $7.72 — the median of 3 independent model estimates as of 2026-08-28, ranging from $2.67 to $21.04. The Quality of Company score is 6.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is DRIO overvalued or undervalued right now?

At $6.77, 2 of 3 active models suggest DRIO may be undervalued, while 1 indicate potential overvaluation. The median of all 3 fair value estimates is $7.72, 14.1% above the current price of $6.77 — a consensus view that DRIO is undervalued. The assessment depends on which methodology best fits DarioHealth Corp.'s business model in Health Information Services.

What does a Quality of Company score of 6.0 mean for DRIO?

DarioHealth Corp.'s QOC of 6.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on DRIO?

CirclFi analyzes DRIO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 3 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on DRIO?

Of the 3 models currently active on DRIO, FTNN Topology is the most bullish at $21.04 per share, and ML Residual Income is the most bearish at $2.67. CirclFi's published fair value for DRIO is the median of that range, $7.72, not either extreme. The gap between the two ends equals 238% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is DRIO a value trap in 2026?

DarioHealth Corp.'s Value Trap score is 53/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries.

Cite this analysis — “According to CirclFi’s 3-model valuation engine, DarioHealth Corp. (DRIO) has a median fair value of $7.72 — 14.1% above the current price of $6.77 — as of 2026-08-28.” Source: circlfi.com/stock/DRIO/ · Methodology
Primary sources for this DRIO valuation
  • Financial statements: DarioHealth Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001533998) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for DRIO as of ; valuations recomputed .